Putting the BRK on breast cancer: From molecular target to therapeutics

Putting the BRK on breast cancer: From molecular target to therapeutics

10.7150/thno.49716

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Ang, Hui Li, Yuan, Yi, Lai, Xianning, Tan, Tuan Zea, Wang, Lingzhi, Huang, Benjamin BoJun, Pandey, Vijay, Huang, Ruby Yun-Ju, Lobie, Peter E, Goh, Boon Cher, Sethi, Gautam, Yap, Celestial T, Chan, Ching Wan, Lee, Soo Chin, Kumar, Alan Prem
مؤلفون آخرون:	PHARMACOLOGY
التنسيق:	Review
اللغة:	English
منشور في:	IVYSPRING INT PUBL 2023
الموضوعات:	Science & Technology Life Sciences & Biomedicine Medicine, Research & Experimental Research & Experimental Medicine Breast tumor kinase (BRK) hallmarks of cancer chemical inhibitors molecular inhibitors meta-analysis PROTEIN-TYROSINE KINASE MAMMARY EPITHELIAL-CELLS LONG-TERM SURVIVAL SH2-KINASE LINKER SIGNALING PATHWAY OLEANOLIC ACID SH3 DOMAIN FACTOR-I PTK6 GROWTH
الوصول للمادة أونلاين:	https://scholarbank.nus.edu.sg/handle/10635/237218
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
المؤسسة:	National University of Singapore
اللغة:	English

مواد مشابهة

Crystallization trials of Refolded Breast Tumor Kinase (BRK) and Peroxisome Proteins
بواسطة: NGUYEN QUOC TOAN
منشور في: (2010)

Molecular docking, conformational analysis, and 3D QSAR model building for TBK-1 inhibition
بواسطة: Rallos, Kiana Casenas, وآخرون
منشور في: (2022)

ENGINEERING NOVEL COMPOUNDS AS SPHINGOSINE KINASE INHIBITORS
بواسطة: WONG LINGKAI
منشور في: (2011)

Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach
بواسطة: Salto-Tellez, M., وآخرون
منشور في: (2014)

Influences of phosphorylation on Thr14/Tyr15 in CDK5 in the presence of roscovitine/ATP and HHASPRK
بواسطة: Jin, H.-X., وآخرون
منشور في: (2014)

CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performance
بواسطة: Wu, Ling, وآخرون
منشور في: (2023)

MECHANISMS OF HYPOXIA-INDUCED GROWTH AND TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKEMIA
بواسطة: MANJERI ADITI SUBRAMANIAM
منشور في: (2019)

Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing
بواسطة: Ho, H.K., وآخرون
منشور في: (2014)

Preclinical characteristics of the irreversible pan-HER kinase inhibitor neratinib compared with lapatinib : implications for the treatment of HER2-positive and HER2-mutated breast cancer
بواسطة: Collins, Denis M., وآخرون
منشور في: (2020)

Potential roles for the PIM1 kinase in human cancer - A molecular and therapeutic appraisal
بواسطة: Shah, N., وآخرون
منشور في: (2012)

Functional Effects of a Novel BIM Deletion Polymorphism in Mediating Resistance to Tyrosine Kinase Inhibitors in Cancer
بواسطة: JUAN WEN CHUN
منشور في: (2014)

Tannic acid, a potent inhibitor of epidermal growth factor receptor tyrosine kinase
بواسطة: Yang, E.B., وآخرون
منشور في: (2014)

Increased iNOS in transformed HPV-immortalized human keratinocytes following chronic ethanol treatment
بواسطة: Warangkana Chunglok
منشور في: (2023)

IDENTIFICATION OF A THERAPEUTIC COMPOUND TARGETING THE CORE ONCOGENIC MACHINERY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
بواسطة: LIM FANG QI
منشور في: (2022)

Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)
بواسطة: Lin, L., وآخرون
منشور في: (2016)

Identification and characterization of a predominant isoform of human MKK3
بواسطة: Han, J., وآخرون
منشور في: (2014)

Activation of protein kinases and the inactivation of protein phosphatase 2A in tumour necrosis factor and interleukin-1 signal-transduction pathways
بواسطة: Guy, G.R., وآخرون
منشور في: (2011)

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
بواسطة: Barrios, C.H., وآخرون
منشور في: (2014)

Molecular dynamics simulations on the inhibition of Cyclin-dependent kinases 2 and 5 in the presence of activators
بواسطة: Zhang, B., وآخرون
منشور في: (2014)

Preclinical characteristics of the irreversible pan- her kinase inhibitor neratinib compared with lapatinib: Implications for the treatment of HER2- positive and HER2-mutated breast cancer
بواسطة: Collins, D.M., وآخرون
منشور في: (2021)

Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors
بواسطة: Chin, T.-M., وآخرون
منشور في: (2021)

Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis
بواسطة: Teo, Y.L., وآخرون
منشور في: (2014)

Exploration of 1-(3-chloro-4-(4-oxo-4H-chromen-2-yl)phenyl)-3-phenylurea derivatives as selective dual inhibitors of Raf1 and JNK1 kinases for anti-tumor treatment
بواسطة: Jin, F., وآخرون
منشور في: (2014)

Identification of potentially useful combinations of epidermal growth factor receptor tyrosine kinase antagonists with conventional cytotoxic agents using median effect analysis
بواسطة: Budman, D.R., وآخرون
منشور في: (2014)

Design and synthesis of receptor tyrosine kinase inhibitors for anticancer treatment
بواسطة: Chawannuch Mudjupa
منشور في: (2023)

NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
بواسطة: Shen, H.-M., وآخرون
منشور في: (2014)

SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF RESORCYLIC ACID LACTONES AND DERIVATIVES AS PROTEIN KINASE INHIBITORS TARGETING TO CANCERS
بواسطة: XU JIN
منشور في: (2015)

Development of phosphodiesterase–protein-kinase complexes as novel targets for discovery of inhibitors with enhanced specificity
بواسطة: Tulsian, Nikhil K., وآخرون
منشور في: (2022)

CLINICAL AND FUNCTIONAL SIGNIFICANCE OF CD151 IN WILDTYPE EGRF NSCLC
بواسطة: WONG HUEE PING AMANDA
منشور في: (2020)

Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitor
بواسطة: Jin, F., وآخرون
منشور في: (2014)

Belinostat and panobinostat (HDACI): In vitro and in vivo studies in thyroid cancer
بواسطة: Chan, D., وآخرون
منشور في: (2014)

Exploring aigialomycin D and its analogues as protein kinase inhibitors for cancer targets
بواسطة: Xu, J., وآخرون
منشور في: (2014)

EXPLORING THE ROLE OF PHARMACOKINETIC ALTERATIONS IN TYROSINE KINASE INHIBITORS (TKIS)-ASSOCIATED TOXICITIES
بواسطة: TEO YI LING
منشور في: (2015)

Crystal structure of human vaccinia-related kinase 1 in complex with AMP-PNP, a non-hydrolyzable ATP analog
بواسطة: Ngow, Yeen Shian, وآخرون
منشور في: (2019)

Immunoglobulin-associated creatine kinase masquerading as macro-creatine kinase type 2 in a statin user
بواسطة: Loh, T.P., وآخرون
منشور في: (2014)

How well does the MESTT correlate with CTCAE scale for the grading of dermatological toxicities associated with oral tyrosine kinase inhibitors?
بواسطة: Chan, A., وآخرون
منشور في: (2014)

Macro creatine kinase
بواسطة: Viroj Wiwanikit
منشور في: (2006)

The Ccl1–Kin28 kinase complex regulates autophagy under nitrogen starvation
بواسطة: Zhu, Jing, وآخرون
منشور في: (2017)

KIT gene mutation analysis in solid tumours: Biology, clincial applications and trends in diagnostic reporting
بواسطة: Tay, C.M., وآخرون
منشور في: (2014)

Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitors
بواسطة: Zhang, C., وآخرون
منشور في: (2014)